| Дата публикации | Название | Авторы |
| 2024 | Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review | Demicheva, E.; Dordiuk, V.; Polanco, Espino, F.; Ushenin, K.; Aboushanab, S.; Shevyrin, V.; Buhler, A.; Mukhlynina, E.; Solovyova, O.; Danilova, I.; Kovaleva, E. |
| 2023 | Combination of a Chaperone Synthesis Inducer and an Inhibitor of GAPDH Aggregation for Rehabilitation after Traumatic Brain Injury: A Pilot Study | Dutysheva, E. A.; Mikhaylova, E. R.; Trestsova, M. A.; Andreev, A. I.; Apushkin, D. Y.; Utepova, I. A.; Serebrennikova, P. O.; Akhremenko, E. A.; Aksenov, N. D.; Bon’, E. I.; Zimatkin, S. M.; Chupakhin, O. N.; Margulis, B. A.; Guzhova, I. V.; Lazarev, V. F. |
| 2023 | Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer’s Disease | Makhaeva, G. F.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Grishchenko, M. V.; Lushchekina, S. V.; Astakhova, T. Y.; Serebryakova, O. G.; Timokhina, E. N.; Zhilina, E. F.; Shchegolkov, E. V.; Ulitko, M. V.; Radchenko, E. V.; Palyulin, V. A.; Burgart, Y. V.; Saloutin, V. I.; Bachurin, S. O.; Richardson, R. J. |
| 2023 | Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease | Makhaeva, G. F.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Lushchekina, S. V.; Astakhova, T. Y.; Timokhina, E. N.; Serebryakova, O. G.; Shchepochkin, A. V.; Averkov, M. A.; Utepova, I. A.; Demina, N. S.; Radchenko, E. V.; Palyulin, V. A.; Fisenko, V. P.; Bachurin, S. O.; Chupakhin, O. N.; Charushin, V. N.; Richardson, R. J. |
| 2024 | Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination | Ivanov, A.; Shamagsumova, R.; Larina, M.; Evtugyn, G. |
| 2018 | Erratum: Understanding taurine CNS activity using alternative zebrafish models (Neuroscience & Biobehavioral Reviews (2017) 83 (525–539) (S0149763417303512) (10.1016/j.neubiorev.2017.09.008)) | Mezzomo, N. J.; Fontana, B. D.; Kalueff, A. V.; Barcellos, L. J. G.; Rosemberg, D. B. |
| 2024 | Fucoidan’s Molecular Targets: A Comprehensive Review of Its Unique and Multiple Targets Accounting for Promising Bioactivities Supported by In Silico Studies | Zayed, A.; Al-Saedi, D. A.; Mensah, E. O.; Kanwugu, O. N.; Adadi, P.; Ulber, R. |
| 2018 | Implementation of an Artificial Neural Network on the Test Barcelona Workstation As a Predictive Model for the Classification of Normal, Mild Cognitive Impairment and Alzheimer’s Disease Subjects Using the Neuronorma Battery | Rivera, N.; Cabrera-Bean, M.; Sánchez-Benavides, G.; Gallego-González, C.; Lupiáñez-Pretel, J. A.; Peña-Casanova, J. |
| 2022 | Indolylazine Derivative Induces Chaperone Expression in Aged Neural Cells and Prevents the Progression of Alzheimer’s Disease | Lazarev, V. F.; Dutysheva, E. A.; Mikhaylova, E. R.; Trestsova, M. A.; Utepova, I. A.; Chupakhin, O. N.; Margulis, B. A.; Guzhova, I. V. |
| 2022 | New TEMPO–Appended 2,2′-Bipyridine-Based Eu(III), Tb(III), Gd(III) and Sm(III) Complexes: Synthesis, Photophysical Studies and Testing Photoluminescence-Based Bioimaging Abilities | Slovesnova, N. V.; Minin, A. S.; Belousova, A. V.; Ustyugov, A. A.; Chaprov, K. D.; Krinochkin, A. P.; Valieva, M. I.; Shtaitz, Y. K.; Starnovskaya, E. S.; Nikonov, I. L.; Tsmokalyuk, A. N.; Kim, G. A.; Santra, S.; Kopchuk, D. S.; Nosova, E. V.; Zyryanov, G. V. |
| 2017 | Zebrafish models in neuropsychopharmacology and CNS drug discovery | Khan, K. M.; Collier, A. D.; Meshalkina, D. A.; Kysil, E. V.; Khatsko, S. L.; Kolesnikova, T.; Morzherin, Y. Y.; Warnick, J. E.; Kalueff, A. V.; Echevarria, D. J. |
